Omzet 2024 * | 48,78 mld. 45,63 mld. | Omzet 2025 * | 50,62 mld. 47,34 mld. | Marktkapitalisatie | 200 mld. 187 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 10,37 mld. 9,7 mld. | Nettowinst (verlies) 2025 * | 11,9 mld. 11,12 mld. | EV/omzet 2024 * | 4,35 x |
Nettoschuld 2024 * | 12,65 mld. 11,83 mld. | Nettoschuld 2025 * | 11,18 mld. 10,46 mld. | EV/omzet 2025 * | 4,17 x |
K/w-verhouding 2024 * |
19,4
x | K/w-verhouding 2025 * |
16,7
x | Werknemers | 76.057 |
Dividendrendement 2024 * |
3,69% | Dividendrendement 2025 * |
3,82% | Vrij verhandelbaar | 85,22% |
Recentste transcriptie over Novartis AG
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 48 | 01-01-05 | |
Director of Finance/CFO | 59 | 01-01-03 | |
Shreeram Aradhye
CTO | Chief Tech/Sci/R&D Officer | 62 | 16-05-22 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Bill Winters
BRD | Director/Board Member | 62 | 01-01-13 |
Simon Moroney
BRD | Director/Board Member | 65 | 28-02-20 |
Chairman | 68 | 01-01-13 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+25,83% | 661 mld. | |
+27,00% | 566 mld. | |
-6,76% | 352 mld. | |
+20,34% | 332 mld. | |
+3,00% | 283 mld. | |
+13,09% | 231 mld. | |
-9,61% | 195 mld. | |
-6,26% | 145 mld. | |
-11,77% | 144 mld. |